Skip to main content
Improve  Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,954 across all filing types
Latest filing 2024-10-25 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
第六届监事会第九次会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a resolution announcement from the Supervisory Board regarding the approval of the company's 2024 third quarter report. It states that the Supervisory Board has reviewed and approved the 2024 third quarter report, confirming its accuracy and completeness. The document itself does not contain the financial report but refers to the full report being available on the designated disclosure website. The document length is short (672 characters) and serves as an announcement of the meeting resolution and approval of the quarterly report, not the report itself. According to the 'Menu vs Meal' rule, this is a Declaration of Voting Results & Voting Rights Announcement (DVA) because it announces the voting outcome on the quarterly report approval by the Supervisory Board.
2024-10-25 Chinese
2024年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "阳普医疗科技股份有限公司2024 年第三季度报告" which translates to "Yangpu Medical Technology Co., Ltd. 2024 Third Quarter Report." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and explanations of financial performance for the third quarter of 2024. The document includes actual financial figures, analysis of changes in financial indicators, and management commentary on business conditions. It explicitly states it is a quarterly report and is unaudited. The length is substantial (15,000 characters), and it is not merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-10-25 Chinese
关于变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 阳普医疗科技股份有限公司 regarding changes in accounting policies. It references new accounting standards issued by the Ministry of Finance of China and details the impact of these changes on financial statement line items such as operating costs and sales expenses. The document includes a statement from the audit committee supporting the changes. The text does not contain full financial statements or comprehensive financial performance data typical of an Annual Report or Interim Report. Instead, it is a regulatory announcement about accounting policy changes and their effects, which aligns with the category of Regulatory Filings (RNS). The document length is short (1939 characters), and it is not a report itself but an announcement of accounting policy changes and related disclosures. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-10-25 Chinese
关于披露2024年第三季度报告的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (407 characters) indicating that the company has approved its 2024 third quarter report and that the full report will be disclosed on a regulatory website the next day. It does not contain the actual financial data or the report itself, but rather serves as a notice to investors about the upcoming report publication. According to the 'MENU VS MEAL' rule, such a brief notice about report availability is classified as a Report Publication Announcement (RPA).
2024-10-25 Chinese
2024年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2024 first extraordinary shareholders' meeting of Yangpu Medical Technology Co., Ltd. It includes details about the meeting date, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and voting process. The content focuses on the declaration of voting results from the shareholders' meeting rather than the meeting materials, presentations, or the full report of the meeting. The document length is short (1656 characters), and it is clearly a voting results announcement. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-09-25 Chinese
北京市中伦(广州)律师事务所关于阳普医疗科技股份有限公司2024年第一次临时股东会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and procedural compliance of a company's 2024 first extraordinary shareholders' meeting. It details the convening, attendance, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or performance data, nor is it a report of financial results or management discussion. It is not an announcement of voting results but a legal opinion on the meeting's compliance with laws and company rules. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories. The document length is under 5,000 characters, and it is a formal legal opinion rather than a report or announcement of a report.
2024-09-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.